Achieve Life Sciences, Inc. (ACHV)
7.24
-0.29
(-3.85%)
USD |
NASDAQ |
Oct 02, 16:00
7.245
0.00 (0.00%)
After-Hours: 20:00
Achieve Life Sciences EPS Diluted (Quarterly) : -0.7996 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7996 |
| March 31, 2026 | -0.1905 |
| December 31, 2025 | -0.2752 |
| September 30, 2025 | -0.2831 |
| June 30, 2025 | -0.3667 |
| March 31, 2025 | -0.3698 |
| December 31, 2024 | -0.3582 |
| September 30, 2024 | -0.3642 |
| June 30, 2024 | -0.2465 |
| March 31, 2024 | -0.2593 |
| December 31, 2023 | -0.2587 |
| September 30, 2023 | -0.3364 |
| June 30, 2023 | -0.4325 |
| March 31, 2023 | -0.5018 |
| December 31, 2022 | -0.8297 |
| September 30, 2022 | -1.349 |
| June 30, 2022 | -1.085 |
| March 31, 2022 | -0.8006 |
| December 31, 2021 | -0.7564 |
| September 30, 2021 | -0.7079 |
| June 30, 2021 | -1.530 |
| March 31, 2021 | -1.304 |
| December 31, 2020 | -1.107 |
| September 30, 2020 | -1.144 |
| June 30, 2020 | -1.675 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.146 |
| December 31, 2019 | -5.914 |
| September 30, 2019 | -9.069 |
| June 30, 2019 | -10.08 |
| March 31, 2019 | -17.57 |
| December 31, 2018 | -10.92 |
| September 30, 2018 | -14.29 |
| June 30, 2018 | -36.40 |
| March 31, 2018 | -48.00 |
| December 31, 2017 | -64.00 |
| September 30, 2017 | -180.00 |
| June 30, 2017 | -219.58 |
| March 31, 2017 | -239.12 |
| December 31, 2016 | -418.00 |
| September 30, 2016 | -264.00 |
| June 30, 2016 | -506.00 |
| March 31, 2016 | -264.00 |
| December 31, 2015 | -132.00 |
| September 30, 2015 | -352.00 |
| June 30, 2015 | -572.00 |
| March 31, 2015 | -440.00 |
| December 31, 2014 | -572.00 |
| September 30, 2014 | -506.00 |
| June 30, 2014 | -1034.00 |
| March 31, 2014 | -1298.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ProText Mobility, Inc. | 0.00 |
| Longevity Health Holdings, Inc. | -0.7608 |
| BioXcel Therapeutics, Inc. | -0.4856 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Agenus, Inc. | -0.0146 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.77M |
| Total Expenses (Quarterly) | 74.77M |
| Enterprise Value | 571.32M |
| Earnings Yield | -21.39% |
| Normalized Earnings Yield | -15.44 |